1-7 of 7
Chien-Chin Lin
Close
Sort by
Journal Articles

Kinome expression profiling improves risk stratification and therapeutic targeting in myelodysplastic syndromes

Chi-Yuan Yao, Chien-Chin Lin, Yu-Hung Wang, Chein-Jun Kao, Cheng-Hong Tsai, Hsin-An Hou, Hwei-Fang Tien, Chia-Lang Hsu, Wen-Chien Chou
Journal: Blood Advances
Blood Adv (2024) 8 (10): 2442–2454.
https://doi.org/10.1182/bloodadvances.2023011512
Published: 2024
Includes: Supplemental data
Journal Articles

High BM plasma S100A8/A9 is associated with a perturbed microenvironment and poor prognosis in myelodysplastic syndromes

Yu-Hung Wang, Chien-Chin Lin, Chi-Yuan Yao, Fabio M. R. Amaral, Shan-Chi Yu, Chein-Jun Kao, Pin-Tsen Shih, Hsin-An Hou, Wen-Chien Chou, Hwei-Fang Tien
Journal: Blood Advances
Blood Adv (2023) 7 (11): 2528–2533.
https://doi.org/10.1182/bloodadvances.2022008958
Published: 2023
Includes: Supplemental data
Journal Articles

A CIBERSORTx-based immune cell scoring system could independently predict the prognosis of patients with myelodysplastic syndromes

Clinical Trials & Observations
Yu-Hung Wang, Hsin-An Hou, Chien-Chin Lin, Yuan-Yeh Kuo, Chi-Yuan Yao, Chia-Lang Hsu, Mei-Hsuan Tseng, Cheng-Hong Tsai, Yen-Ling Peng, Chein-Jun Kao, Wen-Chien Chou, Hwei-Fang Tien
Journal: Blood Advances
Blood Adv (2021) 5 (22): 4535–4548.
https://doi.org/10.1182/bloodadvances.2021005141
Published: 2021
Includes: Supplemental data
Journal Articles

Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML

Clinical Trials & Observations
Cheng-Hong Tsai, Jih-Luh Tang, Feng-Ming Tien, Yuan-Yeh Kuo, Dung-Chi Wu, Chien-Chin Lin, Mei-Hsuan Tseng, Yen-Ling Peng, Mei-Fang Hou, Yi-Kuang Chuang, Ming-Chih Liu, Chia-Wen Liu, Ming Yao, Liang-In Lin, Wen-Chien Chou, Chien-Yu Chen, Hsin-An Hou, Hwei-Fang Tien
Journal: Blood Advances
Blood Adv (2021) 5 (10): 2456–2466.
https://doi.org/10.1182/bloodadvances.2020003738
Published: 2021
Includes: Supplemental data
Journal Articles

A 4-gene leukemic stem cell score can independently predict the prognosis of myelodysplastic syndrome patients

Clinical Trials & Observations
Yu-Hung Wang, Chien-Chin Lin, Chi-Yuan Yao, Chia-Lang Hsu, Hsin-An Hou, Cheng-Hong Tsai, Wen-Chien Chou, Hwei-Fang Tien
Journal: Blood Advances
Blood Adv (2020) 4 (4): 644–654.
https://doi.org/10.1182/bloodadvances.2019001185
Published: 2020
Includes: Supplemental data
Journal Articles

Phf6-null hematopoietic stem cells have enhanced self-renewal capacity and oncogenic potentials

Yueh-Chwen Hsu, Tsung-Chih Chen, Chien-Chin Lin, Chang-Tsu Yuan, Chia-Lang Hsu, Hsin-An Hou, Chein-Jun Kao, Po-Han Chuang, Yu-Ren Chen, Wen-Chien Chou, Hwei-Fang Tien
Journal: Blood Advances
Blood Adv (2019) 3 (15): 2355–2367.
https://doi.org/10.1182/bloodadvances.2019000391
Published: 2019
Includes: Supplemental data
Journal Articles

A 4-lncRNA scoring system for prognostication of adult myelodysplastic syndromes

Clinical Trials & Observations
Chi-Yuan Yao, Ching-Hsuan Chen, Huai-Hsuan Huang, Hsin-An Hou, Chien-Chin Lin, Mei-Hsuan Tseng, Chein-Jun Kao, Tzu-Pin Lu, Wen-Chien Chou, Hwei-Fang Tien
Journal: Blood Advances
Blood Adv (2017) 1 (19): 1505–1516.
https://doi.org/10.1182/bloodadvances.2017008284
Published: 2017
Includes: Supplemental data